According to the latest WHO files, the Sinopharm vaccine is now in progress of assessment, while the Sinovac vaccine submitted its data for inspection in mid-January with more dossiers expected for submission by the end of this month. Anticipated decisions from the WHO on both vaccines are expected in March.